Literature DB >> 29504329

Outcome Of Trans Rectal Ultrasound Guided Twelve Core Biopsy Of Prostate For The Detection Of Prostate Cancer- A Single Centre Experience.

Muhammad Waqas1, Durre Shohab1, Mohammad Athar Khawaja1, Afifa Masood1, Muhammad Waqas Iqbal1, Saeed Akhter1.   

Abstract

BACKGROUND: This study was conducted to determine the outcome of trans-rectal ultrasound (TRUS) guided biopsy of prostate for the detection of prostatic carcinoma in a single tertiary care hospital in Pakistan.
METHODS: This is a retrospective study including three hundred and eightythree patients who underwent trans rectal ultrasound guided biopsy of prostate in a single tertiary care hospital. Indications for biopsy were raised prostate specific antigen (PSA), abnormal digital rectal examination (DRE) and/or both. Twelve core biopsy of prostate was done..
RESULTS: The overall detection rate of prostate cancer was 59%. Prostate cancer detection in various PSA ranges of 0-3.99, 4-9.99, 10-19.99 and >20 ng/ml are 22.22%, 37.88%, 50.0% and 89.9%. PSA density >0.15ng/ml2 can diagnose 74.5% of patients with cancer. Prostate cancer detection rate based on abnormal DRE is 64.6% compared to 60.8% detected by PSA>4 ng/ml.
CONCLUSIONS: In conclusion raised PSA, smaller prostate volume, abnormal DRE and raised PSA density are associated with greater chances of detection of prostate carcinoma.

Entities:  

Keywords:  Digital rectal examination; Prostatezzm321990volume, Trans rectal ultrasound; Prostate Specific antigen; Prostate cancer

Mesh:

Year:  2018        PMID: 29504329

Source DB:  PubMed          Journal:  J Ayub Med Coll Abbottabad        ISSN: 1025-9589


  1 in total

1.  Magnetic Resonance Imaging (MRI)-Targeted Biopsy in Patients with Prostate-Specific Antigen (PSA) Levels <20 ng/mL: A Single-Center Study in Northeastern China.

Authors:  Zhihong Dai; Yangyang Liu; Zhao Huangfu; Liang Wang; Zhiyu Liu
Journal:  Med Sci Monit       Date:  2021-08-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.